The Drug Eluting Stents Center

Filter Your Results

 

News

 

Strategies for Femoropopliteal In-Stent Restenosis

Ehrin J. Armstrong, MD, MSc

October 2014—An overview on the safety and efficacy of current devices and treatment techniques to overcome this challenging but often-occurring clinical presentation.

When would you elect to use a DCB versus a DES for SFA interventions, and what guides your decision making?

With Francesco Liistro, MD; Sebastian Sixt, MD; Gary Ansel, MD; and Marianne Brodmann, MD

October 2014— FRANCESCO LIISTRO, MD Department of Cardiovascular Disease San Donato Hospital Arezzo, Italy He has stated that he has no financial interests related to this article…

Cook Medical Begins Enrollment of Zilver PTX Trial in China

August 15, 2014 -- Cook Medical announced that it has enrolled the first patient in the clinical study in China of its Zilver PTX paclitaxel-eluting peripheral stent. The firs…

Cook Medical Makes Zilver PTX Drug-Eluting Stent Available in Canada

June 5, 2014 -- Cook Medical announced the launch of the Zilver PTX paclitaxel-eluting peripheral stent in Canada at the Canadian Interventional Radiology Association (CIRA) m…

Japanese Postmarket Surveillance Data for Zilver PTX Presented at EuroPCR 2014

May 29, 2014 -- At last week’s EuroPCR 2014 meeting, Hiroyoshi Yokoi, MD, of Fukuoka Sanno Hospital presented 1-year data from from a postmarket surveillance study of 90…

Refining Strategies for the SFA

With Krishna Rocha-Singh, MD, FACC, FAHA, FSCAI, FSVM; Peter A. Schneider, MD; Gunnar Tepe, MD; and Professor Thomas Zeller, MD

March 2014—A panel of experts discusses the promise of drug-eluting balloons and other techniques for treating SFA and popliteal lesions.

Alvimedica Launches Cre8 BTK Drug-Eluting Stent in Europe

April 7, 2014 -- Alvimedica Medical Technologies (Catalca, Turkey) announced the launch of the Cre8 BTK drug-eluting stent (DES), a polymer-free device for the treatment of be…

Twelve-Month Results of Zilver PTX in Long Femoropopliteal Lesions Presented at LINC

January 29, 2014 -- At LINC 2014: The Leipzig Interventional Course in Leipzig, Germany, Prof. Thomas Zeller, MD, presented the 12-month results of a postmarket study eva…

 

advertisement

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.